HeartSciences Inc.HSCSNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank80
3Y CAGR-11.6%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-11.6%/yr
Annual compound
Percentile
P80
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 52.37% |
| 2024 | 16.97% |
| 2023 | -18.01% |
| 2022 | 75.69% |
| 2021 | -16.26% |
| 2020 | 0.00% |